Skip to main content Skip to main navigation menu Skip to site footer
CUAJ|JUAC
  • Home
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Issues
  • Guidelines
  • Supplements & Abstracts
  • CPD Credits
Search
  • Register
  • Login
  1. Home /
  2. Archives /
  3. Vol. 10 No. 11-12 (2016): CUAJ December Suppl 7

Vol. 10 No. 11-12 (2016): CUAJ December Suppl 7

Published: 2016-12-15

Supplement-Introduction

  • Sunitinib: 10 years of clinical experience in the treatment of advanced renal cell carcinoma

    Anil Kapoor
    S235
    • PDF

Supplement-Review

  • First-line treatment options in metastatic renal cell cancer

    Anil Kapoor
    S236-8
    • PDF
  • Practical first-line management of renal cell carcinoma in a community practice

    Henry Conter
    S239-41
    • PDF
  • Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors

    Naveen S. Basappa
    S242-4
    • PDF
  • Sunitinib side effects as surrogate biomarkers of efficacy

    Christian Kollmannsberger
    S245-7
    • PDF
  • Sunitinib toxicity management – a practical approach

    Sandeep Sehdev
    S248-51
    • PDF
  • Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?

    Georg A. Bjarnason
    S252-5
    • PDF
  • The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma

    Daniel Y.C. Heng
    S256-8
    • PDF
Most Read Last Week
  • UPDATE – 2022 Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH)
    156
  • UPDATE – Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies (Full-text)
    87
  • The effect of lowering cholesterol through diet on serum prostate-specific antigen levels: A secondary analysis of clinical trials
    43
  • Testicular cancer survivorship: Long-term toxicity and management
    39
  • UPDATE – Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies (Summary of changes)
    34

grouped_ads



For advertising information, click here

JOB POSTINGS


NEW! UBC
Assistant Professor, Endourology

NEW! UBC
Assistant Professor, Uro-Oncology


NOSM
Minimally Invasive Urologic Surgery Fellowship Program

University of Ottawa
Kidney Transplant/ Advanced MIS Fellowship

 






 

twitter-feed

@CUAJOURNAL

Tweets by CuaJournal

Language

  • English
  • Français (Canada)

Canadian Urological Association Journal eISSN 1920-1214 | Published by the Canadian Urological Association, 185 Dorval Avenue, Dorval, QC, Canada, H9S 5J9
T. 514-395-0376 | F. 514-395-1664
Contact | Privacy Policy | Follow @CanUrolAssoc

More information about the publishing system, Platform and Workflow by OJS/PKP.